CIDI (03881.HK) Sets 30 Mar 2026 Board Meeting to Approve FY2025 Results

Bulletin Express
Mar 13

CiDi Inc. (CIDI, stock code 03881.HK) announced that its board of directors will convene on 30 March 2026 to review and approve the Group’s audited financial results for the year ended 31 December 2025 and to authorize their publication.

The notice, dated 13 March 2026, states that additional routine matters may also be addressed during the session.

Board composition at the time of the announcement is as follows: • Executive Directors: Dr. Ma Wei and Dr. Albert S. Hu (also Chief Executive Officer) • Non-Executive Directors: Prof. Li Zexiang, Ms. Yang Xi and Dr. Li Zhiyong • Independent Non-Executive Directors: Dr. Li Xiaoyuan, Prof. Tan Guangrong and Mr. Zhang Jiangang

The company did not disclose any financial figures in this notice; those details are expected upon release of the FY2025 results after board approval.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10